SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-19-000131
Filing Date
2019-04-30
Accepted
2019-04-30 12:58:12
Documents
36
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QTR. MARCH 31, 2019 bfnh0424201910qmarch2019.htm 10-Q 152384
2 CERTIFICATION ex311.htm EX-31.1 4937
3 CERTIFICATION ex312.htm EX-31.2 4956
4 CERTIFICATION ex321.htm EX-32.1 2210
5 CERTIFICATION ex322.htm EX-32.2 2161
12 bfnh0424201910qmarch2019001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-19-000131.txt   884035

Data Files

Seq Description Document Type Size
6 bfnh-20190331.xml EX-101.INS 79173
7 bfnh-20190331.xsd EX-101.SCH 12610
8 bfnh-20190331_cal.xml EX-101.CAL 20676
9 bfnh-20190331_def.xml EX-101.DEF 17984
10 bfnh-20190331_lab.xml EX-101.LAB 87837
11 bfnh-20190331_pre.xml EX-101.PRE 67493
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

IRS No.: 743078125 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 19779950
SIC: 3826 Laboratory Analytical Instruments